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INTRODUCTION
It is generally accepted that PbO2 reflects
the balance between O2 delivery and con-
sumption (Diringer et al., 2007; Diringer,
2008). However, implementation in the
perioperative period of various ventila-
tory modes using high FiO2 leads to a
dramatic and non-physiologic increase in
PbO2 with approximating levels of 147
± 36mmHg (McLeod et al., 2003). This
phenomenon doesn’t correlate with the
extent of slight increase in arterial O2 con-
tent. At the same time, the jugular venous
PO2 increases only slightly (37–40mmHg)
(Forkner et al., 2007).Moreover, hyperoxia
does not affect significantly the regional
CBF, and there is no improvement in
cerebral metabolism with oxygen therapy
(Magnoni et al., 2003; Diringer et al., 2007;
Diringer, 2008; Xu et al., 2012).
The PbO2 increase is more pronounced
in edematous (but not necrotized)
brain tissues compared to normal areas
(Meixensberger et al., 1993). Although,
this can be considered a positive phe-
nomenon, it masks the real state of rCBF
and local oxidative metabolism. Recording
of high PbO2 absolute values may create
a false impression of safety and nega-
tively impact the clinical decision making.
Apparently, better indicators of the status
of energy exchange in the brain tis-
sue are needed for practical use in the
perioperative and critical care settings.
BRAIN TISSUE OXYGEN REACTIVITY:
CLINICAL IMPLICATIONS
Dynamic assessment of relative changes in
brain oxygenation to monitor the brain
functionality is a better approach com-
pared to relying on a single parameter.
With such monitoring, both the current
status of brain tissue oxygenation and
the functional reserve capabilities can be
accomplished.
Brain tissue oxygen reactivity (BTOR)
is the measure (in percents) of PbO2
changes relative to changes in PaO2
(PbO2/PaO2) with oxygen inhalation
(Johnston et al., 2003). The latter param-
eter can be easily adjusted to reach BTOR
optimal values. The technique of measure-
ment includes increasing the FiO2 up to
1.0 with simultaneous recording of the
PaO2 and PbO2 values.
Literature reports indicate that high
BTOR values within the first 24 h after TBI
are considered an indicator of unfavorable
outcome and negatively correlate with the
Glasgow Outcome Score (van Santbrink
et al., 1996; Menzel et al., 1999).
It is not mandatory to apply the max-
imal FiO2 of 1.0 to calculate the BTOR.
Any other high inspired O2 levels can
be applied that will produce significant
PbO2 changes within 20min. Such a
time period is considered the minimal
required interval adequate for equilibra-
tion and meaningful assessment. During
this short period, the respiration, regional
metabolism and the rCBF are assumed to
remain stable, and the calculated values of
PbO2/PaO2 will indirectly characterize
the rCBF.
Low BTOR is considered a positive phe-
nomenon even when the absolute PbO2
values decrease, unless regional hypoper-
fusion (<20ml/100 g/min) exists (Hlatky
et al., 2008). Simultaneous elevations of
PbO2 and PbO2/PaO2 values reflect
the imbalance between the oxygen delivery
and consumption.
Under normal cardio-respiratory con-
ditions, when the right to left pulmonary
shunting is negligible, the FiO2 is
proportional to PaO2. On the other
hand, PbO2 itself correlates with PaO2.
Therefore, one can presume that FiO2 is
proportional to PbO2. Taking this into
account, the formula used to calculate
the BTOR can be modified to evalu-
ate the correlation between the changes
in PbO2 and FiO2. This new parameter
(PbO2/FiO2) is considered an equiva-
lent of BTOR and can be easily calculated.
This is a simple and practical approach to
BTOR assessment that can be readily used
at bedside. Such an approach will allow
for dynamic assessment of tissue oxygen
reactivity.
BTOR: PATHOPHYSIOLOGY
In order to illustrate the importance of
BTOR as an ultimate indicator of bal-
ance between the rCBF, oxygen delivery
and consumption and justify the need for
its monitoring, the hypothesis of hyper-
reactive, non-physiologic, luxurious PbO2
elevation is proposed.
We hypothesize that the significant
increase of PbO2 with hyperoxia in the
injured brain is explained by an excessive
right shift of the oxyhemoglobin dissocia-
tion curve with resultant significant reduc-
tion in hemoglobin’s affinity to oxygen
molecules at the microcirculatory level.
This is a result of a mismatch between
the rCBF and existing cerebral metabolic
rate of oxygen (CMRO2), which leads to
accumulation of CO2, converted by ery-
throcyte carboanhydrase into HCO−3 and
H+ ions (at a 1000 times faster rate com-
pared to plasma and extracellular space).
It is known that CO2 and H+, which are
produced during the tissue metabolism,
are heterotropic effectors of hemoglobin
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that enhance oxygen release (Berg et al.,
2002). The latter ions bind to hemoglobin
with release of oxygen. With decrease in
rCBF and/or relative increase of CMRO2,
hemoglobin gets saturated with protons
and practically loses its affinity to oxygen
in the microcirculatory bed.
The role of CO2-induced local increase
of PO2 is particularly important in the
brain tissue where, under normal con-
ditions (glucose-dependant metabolism
without chronic fasting), the respiratory
quotient equals 1 and the CO2 production
almost 1.25 times exceeds that of the other
tissues.
According to the above mentioned con-
siderations, the rCBF determines PbO2
values via two principal mechanisms: (a)
as an oxygen delivery mechanism within
the arterial compartment and (b) via a
“non-physiologic” right shift of the oxy-
hemoglobin dissociation curve as a result
of decreased removal rate of the flow-
dependent metabolites in the microcircu-
latory bed.
Many drugs and techniques used com-
monly during therapy of severe TBI,
including manitol, sodium thiopenthal,
ketorolac, nimodipine, intra-arterial
papaverine, hypothermia, deep sedation,
etc., can reduce the PbO2 in the damaged
tissue (Steiner et al., 2001; Gupta et al.,
2002; Stiefel et al., 2004, 2006; Sakowitz
et al., 2007). On the other hand, the
effects of medically induced augmenta-
tion of cerebral perfusion pressure on
cerebral oxygenation are difficult to pre-
dict (Sahuquillo et al., 2000; Imberti et al.,
2002; Le Roux and Oddo, 2013). In addi-
tion, Zygun et al. (2009) showed that even
though transfusion of packed red blood
cells in TBI patients may improve the
brain tissue oxygenation, it won’t have an
appreciable effect on cerebral metabolism
(Zygun et al., 2009). Thus, there is a
complex interaction of multiple factors
influencing the functional and metabolic
activity of the injured brain including
injury-related pathological mechanisms,
drugs and methods used to manage these
patients. Their overall effects are not
straightforward and cannot be anticipated
easily in an individual case. Apparently,
Monitoring of PbO2 in these patients will
not provide reliable feedback and may be
misleading in some cases. It is not justi-
fied to treat the severe TBI patients relying
only on the PbO2 as an indicator of ade-
quacy of cerebral metabolism. Instead,
dynamic oxygen reactivity should be rou-
tinely monitored as an indicator of overall
brain tissue oxygenation and metabolism.
CALCULATIONS
Assuming CBF and CMRO2 stability dur-
ing oxygen therapy and equivalence of
PbO2 with capillary PO2, (Kett-White
et al., 2002) we can modify the stan-
dard formula for calculation of arterio-
venous difference in oxygen (Kett-White
et al., 2002) to determine the changes
in hemoglobin saturation in the capillary
blood:
Sv.aO2 − Sv.bO2 = [CtaO2 (a) − CtbO2 (a)
− 0.003 ∗ (PbaO2 − PbbO2)] /1.34xHb
where Sv.aO2 and Sv.bO2 are oxygen satu-
ration at distal microcirculatory level after
and before inhalation of oxygen; CtaO2 (a)
and CtbO2 (a) are arterial oxygen content
values after and before initiating oxygen
therapy; PbaO2 and PbbO2 are PbO2 val-
ues after and before starting inhalation of
oxygen; and Hb is hemoglobin concentra-
tion in g/dL.
For example, if we increase PbO2 from
P50 = 35mmHg (if hemoglobin satura-
tion is 0.5 or 50%) to 100mmHg and
assume a change in CtO2 (a) equal to 1
vol. %, the hemoglobin saturation at dis-
tal microcirculatory level will change in
the following way (assuming a hemoglobin
concentration 12 g/dL):
SvaO2 − SvbO2 = [1 − 0.003 ∗ (100 − 35)]
/1.34x12 = 0.05 or 5 %
This means that the distal microcircula-
tory oxygen saturation under these arterial
conditions (PbO2 = 100mmHg) will only
increase 50% + 5% = 55%.
Calculations show the weak affinity of
hemoglobin to oxygen under these condi-
tions which results in allocation of addi-
tional oxygen amounts out of hemoglobin
with creation of abnormally high PbO2 in
injured brain tissue areas.
CONCLUSIONS
Monitoring of BTOR or its equivalent
PbO2/FiO2 is indicated during the
intensive therapy of TBI patients. Both
indices reflect the actual status of cerebral
oxidative metabolism and help to reduce
the risk of management errors which are
otherwise masked by high FiO2-induced
“adequate” PbO2 absolute values.
Blood transfusions, controlled hyper-
ventilation and restoration of the regional
acid-base balance should be performed
under the guidance of above mentioned
indices.
Further studies will help to establish the
role of BTOR and PbO2/FiO2 moni-
toring in assessment of metabolic changes
and adaptations taking place in the injured
brain during the acute phase of TBI.
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